| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900053 | IBI306 | tafolecimab | Injection | Biological Products(1) | New Drug Application | 2019-06-12 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | In Review | 2019-06-10 | view |